Clune & Associates’s Abbott ABT Stock Holding History

Clune & Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.19M	Sell	12,045 -485	-4%	-$50.6K	0.18%	75
2026 Q2	$1.14M	Buy	12,530 +11	+0.1%	+$1K	0.17%	78
2026 Q1	$1.29M	Sell	12,519 -2,058	-14%	-$232K	0.24%	78
2025 Q4	$1.83M	Sell	14,577 -103	-0.7%	-$13.1K	0.39%	64
2025 Q3	$1.97M	Sell	14,680 -114	-0.8%	-$15K	0.49%	56
2025 Q2	$2.01M	Sell	14,794 -123	-0.8%	-$16.2K	0.55%	51
2025 Q1	$1.98M	Buy	14,917 +376	+3%	+$47.9K	0.61%	50
2024 Q4	$1.64M	Buy	+14,541	New	+$1.68M	0.55%	53

Other funds holding ABT

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.66B AUM 23.19% 1-Year Est. Return

Clune & Associates's ABT Position: Q3 2026 in Review

Clune & Associates reduced its Abbott (ABT) stake by 3.9% in Q3 2026, selling an estimated $50.6K and leaving 12,045 shares worth $1.19M. The position accounts for 0.18% of the portfolio, ranked #75.

Clune & Associates first reported a position in ABT in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.01M in Q2 2025. 923 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

Clune & Associates held 12,045 shares of Abbott worth $1.19M as of Q3 2026.
Clune & Associates sold 485 Abbott shares in Q3 2026, an estimated $50.6K.
Abbott made up 0.18% of Clune & Associates's portfolio in Q3 2026, its #75 holding.
Clune & Associates first reported a position in Abbott in Q4 2024 and has held it in 8 quarters since.
Clune & Associates's Abbott position peaked at $2.01M in Q2 2025.
923 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Clune & Associates's 13F filing for Q3 2026, filed 8 Oct 2026.